-
1دورية أكاديمية
المصدر: Drug Design, Development and Therapy, Vol Volume 16, Pp 2383-2393 (2022)
مصطلحات موضوعية: nalbuphine, intravenous, liver dysfunction, uplc-ms/ms, pharmacokinetics, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Gao, XN, Yan, F, Lin, J, Gao, L, Lu, XL, Wei, SC, Shen, N, Pang, JX, Ning, QY, Komeno, Y, Deng, AL, Xu, YH, Shi, JL, Li, YH, Zhang, DE, Nervi, C, Liu, SJ, Yu, L
المصدر: Leukemia. 29(8)
مصطلحات موضوعية: Rare Diseases, Pediatric Cancer, Childhood Leukemia, Cancer, Pediatric Research Initiative, Genetics, Hematology, Pediatric, Orphan Drug, 2.1 Biological and endogenous factors, Aetiology, Animals, Apoptosis, Blotting, Western, Cell Proliferation, Cell Transformation, Neoplastic, Chromatin Immunoprecipitation, Core Binding Factor Alpha 2 Subunit, DNA (Cytosine-5-)-Methyltransferases, DNA Methylation, DNA Methyltransferase 3A, Flow Cytometry, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Immunoenzyme Techniques, Leukemia, Myeloid, Acute, Mice, Oncogene Proteins, Fusion, Promoter Regions, Genetic, RNA, Messenger, RUNX1 Translocation Partner 1 Protein, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Transcriptional Activation, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, Clinical Sciences, Oncology and Carcinogenesis, Immunology
URL الوصول: https://escholarship.org/uc/item/698126wf
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Li YQ; Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China.; Medical School of Chinese PLA, Beijing 100853, China., Shao YL; Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China.; Medical School of Chinese PLA, Beijing 100853, China., Li MY; Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China.; Medical School of Chinese PLA, Beijing 100853, China., Wang LL; Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China., Gao XN; Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China.E-mail:gaoxn@263.net.
المصدر: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Apr; Vol. 32 (2), pp. 382-388.
نوع المنشور: English Abstract; Journal Article
بيانات الدورية: Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE
مواضيع طبية MeSH: Jumonji Domain-Containing Histone Demethylases*/genetics , Leukemia, Myeloid, Acute*/genetics, Humans ; Cell Line, Tumor ; Methylation ; RNA, Messenger/genetics ; RNA, Small Interfering/genetics
-
10دورية أكاديمية
المؤلفون: Gao XN; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China. gaoxn@263.net., Su YF; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China., Li MY; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China.; Graduate School, Chinese PLA General Hospital, Beijing, 100853, China., Jing Y; Department of Hematology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China., Wang J; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China., Xu L; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China., Zhang LL; Department of Hematology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China., Wang A; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China., Wang YZ; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China., Zheng X; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China., Li YF; Department of Hematology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China., Liu DH; Senior Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 East Main Street, Beijing, 100071, China. daihongrm@163.com.
المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Aug; Vol. 72 (8), pp. 2769-2782. Date of Electronic Publication: 2023 May 11.
نوع المنشور: Clinical Trial, Phase II; Journal Article
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
مواضيع طبية MeSH: Immune Checkpoint Inhibitors*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy, Humans ; Decitabine ; Cytarabine/therapeutic use ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
SCR Protocol: CAG protocol